These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 15069793)

  • 21. Stent prices down, but not for long.
    Hosp Mater Manage; 2002 Nov; 27(11):1, 12-3. PubMed ID: 12442555
    [No Abstract]   [Full Text] [Related]  

  • 22. Drug-eluting stents: the price is not right.
    Eisenberg MJ
    Circulation; 2006 Oct; 114(16):1745-54; discussion 1754. PubMed ID: 17043178
    [No Abstract]   [Full Text] [Related]  

  • 23. Drug-eluting stents: a pharmacoclinical perspective.
    Thomas MK; Gupta YK
    Natl Med J India; 2006; 19(4):195-9. PubMed ID: 17100106
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Coronary artery bypass surgery or drug eluting stent for unprotected left main coronary artery disease.
    Gupta S; Gupta BM
    J Assoc Physicians India; 2007 Apr; 55():287-91. PubMed ID: 17694790
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Are drug-eluting stents cost-effective? It depends on whom you ask.
    Ryan J; Cohen DJ
    Circulation; 2006 Oct; 114(16):1736-43; discussion 1744. PubMed ID: 17043177
    [No Abstract]   [Full Text] [Related]  

  • 26. Clinical outcomes following percutaneous coronary intervention with drug-eluting vs. bare-metal stents in dialysis patients.
    Halkin A; Selzer F; Marroquin O; Laskey W; Detre K; Cohen H
    J Invasive Cardiol; 2006 Dec; 18(12):577-83. PubMed ID: 17197706
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The paclitaxel-eluting stent in percutaneous coronary intervention: Part II. Comparison with the sirolimus-eluting stent, economics, and unanswered questions.
    Ray GM; Nawarskas JJ; Frishman WH
    Cardiol Rev; 2006; 14(3):143-50. PubMed ID: 16628023
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Efficacy and safety of drug-eluting stents: current best available evidence.
    Raja SG; Dreyfus GD
    J Card Surg; 2006; 21(6):605-12; discussion 613-4. PubMed ID: 17073969
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Drug-eluting stents.
    García-García HM; Vaina S; Tsuchida K; Serruys PW
    Arch Cardiol Mex; 2006; 76(3):297-319. PubMed ID: 17091802
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Drug-eluting stents: beyond the hyperbole.
    Hunter WL
    Adv Drug Deliv Rev; 2006 Jun; 58(3):347-9. PubMed ID: 16600419
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A randomized comparison of sirolimus-eluting stent implantation with zotarolimus-eluting stent implantation for the treatment of total coronary occlusions: rationale and design of the PRImary Stenting of Occluded Native coronary arteries III (PRISON III) study.
    Suttorp MJ; Laarman GJ;
    Am Heart J; 2007 Sep; 154(3):432-5. PubMed ID: 17719285
    [TBL] [Abstract][Full Text] [Related]  

  • 32. XIENCE V everolimus-eluting coronary stent system: a novel second generation drug-eluting stent.
    Beijk MA; Piek JJ
    Expert Rev Med Devices; 2007 Jan; 4(1):11-21. PubMed ID: 17187467
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Drug-eluting stents boost prices.
    Hosp Mater Manage; 2004 Jan; 29(1):1, 12-4. PubMed ID: 14768436
    [No Abstract]   [Full Text] [Related]  

  • 34. The emerging market dynamics of targeted therapeutics.
    Calfee JE; Dupré E
    Health Aff (Millwood); 2006; 25(5):1302-8. PubMed ID: 16966726
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Drug-eluting coronary stents: many meta-analyses, little benefit.
    Prescrire Int; 2009 Apr; 18(100):70-4. PubMed ID: 19585727
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Review of the TAXUS Liberté SR paclitaxel-eluting coronary stent.
    Ahmed WH
    Expert Rev Med Devices; 2007 Mar; 4(2):117-20. PubMed ID: 17359218
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A stent is not just a stent: Stent construction and design do matter in its clinical performance.
    Lau KW; Johan A; Sigwart U; Hung JS
    Singapore Med J; 2004 Jul; 45(7):305-11; quiz 312. PubMed ID: 15221045
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Medical/surgical advances. The unkindest cut.
    Haugh R
    Hosp Health Netw; 2002 Nov; 76(11):14, 16. PubMed ID: 12465578
    [No Abstract]   [Full Text] [Related]  

  • 39. On- versus off-label use of drug-eluting coronary stents in clinical practice (report from the American College of Cardiology National Cardiovascular Data Registry [NCDR]).
    Rao SV; Shaw RE; Brindis RG; Klein LW; Weintraub WS; Peterson ED;
    Am J Cardiol; 2006 May; 97(10):1478-81. PubMed ID: 16679087
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Benefits and risks of drug-eluting stents].
    Zijlstra F
    Ned Tijdschr Geneeskd; 2007 May; 151(18):1005-7. PubMed ID: 17508683
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.